Table 5 Mortality and HF-related hospitalization of the cohort.

From: Renal protective effect of sacubitril/valsartan in patients with heart failure

Outcome variables Total n = 274 Sacubitril/valsartan n = 137 Valsartan n = 137
Cardiovascular death, n (%) 17 (6.20%) 4 (2.92%) 13 (9.49%)
All-cause death, n (%) 21 (7.66%) 5 (3.65%) 16 (11.68%)
HF-related hospitalization, n (%) 42 (15.33%) 25 (18.25%) 17 (12.41%)
  1. HF heart failure.